Concepedia
Statistics
Publications
15
Citations
1.2K
H-Index
14
Active since
2007
Affiliations
Charité - Universitätsmedizin Berlin(Current)
Bayer (Germany)
Centre Léon Bérard
Universitätsklinikum Würzburg
National Cancer Centre Singapore
Hendrik Nogai is an author at Charité - Universitätsmedizin Berlin specializing in oncology, molecular oncology, and medicine.
Publications per year
2007–2021
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
Matthias Pfeifer, Michael Grau, Dido Lenze et al. · Proceedings of the National Academy of Sciences · 2013 · 262 citations
Medicine, Molecular Biology, Oncology +16
Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
Stephan Hailfinger, Hendrik Nogai, Christiane Pelzer et al. · Proceedings of the National Academy of Sciences · 2011 · 236 citations
Life Sciences, Immunology, Molecular Biology +15
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schüler, Byoung Chul Cho, Cyrus Sayehli et al. · The Lancet Oncology · 2019 · 174 citations
Medicine, Oncology, Pharmacology +11
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Hendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger et al. · Blood · 2013 · 88 citations
Life Sciences, Molecular Biology, Oncology +14
Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Theo D. Kim, Michaela Schwarz, Hendrik Nogai et al. · Thyroid · 2010 · 79 citations
Medicine, Endocrinology, Oncology +15
1–5 of 15